Skip to content

Measure of Engagement of Epilepsy Patients in Messaging Groups

Measure of Engagement of Epilepsy Patients in Messaging Groups and Group Characteristics That Influence Engagement.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03076645
Enrollment
202
Registered
2017-03-10
Start date
2016-10-01
Completion date
2017-08-10
Last updated
2017-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

This study will measure the engagement of people with epilepsy in a mobile phone based messaging platform as well as understand if there is an impact on their self-management

Detailed description

The primary purpose of this study is to assess a person with epilepsy's level of usage of a mobile messaging application for peer support. The secondary purpose is to understand what characteristics of their group drive different levels of usage and improvements in self-management. Participants can participate as much or little as they want for a minimum of six weeks. Participants will complete an initial and a final questionnaire.

Interventions

BEHAVIORALFacilitator support and education

Group engaged with facilitator support and education

Sponsors

Royal Free Hospital NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age, diagnosis of epilepsy, have access to a smartphone capable of running messaging application

Exclusion criteria

* A diagnosis of learning disability/difficulty, significant mental health conditions; those in care, bereaved, or prisoners. Any other vulnerable individuals (individuals unable to protect themselves against significant harm or exploitation)

Design outcomes

Primary

MeasureTime frameDescription
Engagement6 weeksAverage participant number of posts over time frame assessed by tracking number of participant entries

Secondary

MeasureTime frameDescription
Epilepsy self-managementChange in Baseline to 6 weeksPatient activation measure based on self-reported questionnaire
Epilepsy medication adherenceChange in Baseline to 6 weeksMedication adherence based on self-reported questionnaire
Epilepsy quality of lifeChange in Baseline to 6 weeksQuality of life in epilepsy metric based on self-reported questionnaire

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026